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Background: Mesenchymal stem cells (MSCs) in tumors have emerged as progenitors involved in stroma formation and
metastasis of cancers, partially owing to their abilities to differentially express paracrine factors related to the proliferation
and invasion of cancer cells. In this regard, increasing evidence has shown that MSCs have impacts on the malignancy of
colon cancer, however, the underpinning mechanisms by which MSCs promote cancer metastasis remain elusive.
Methods: To investigate the crosstalk between adipose-derived MSCs (AMSCs) isolated from adipose tissues and colon
cancer cells, a co-culture transwell model of AMSCs and colon cancer cells was employed, and the activation of Wnt sig-
naling and paracrine factors in colon cancer cells and AMSCs were measured.
Results: The results showed that AMSCs could enhance the metastatic capacity of colon cancer cells with an elevated
expression of mesenchymal-epithelial transition (EMT)-associated genes in a contact-dependent manner. Reciprocally, colon
cancer cells were able to induce AMSCs to produce metastasis-related factors and cytokines, such as FGF10, VEGFC and
matrix metalloproteinases (MMPs) in part through a mechanism of an activation of Wnt signaling, by which these factors
in turn activate Wnt signaling of colon cancer cells. Intriguingly, an inhibition of Wnt signaling leads a reduced capacity of
invasion and colony formation of colon cancer cells in vitro, and the tumorigenicity of cancer cells in a murine model.
Conclusions: These findings thus suggest that the crosstalk between the Wnt signaling of cancer cells and paracrine
factors of AMSCs has an implication in colon cancer malignancy. This study thus uncovers a novel
Wnt-paracrine factors mediated-crosstalk between colon cancer cells and AMSCs in cancer malignancy.
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The tumor and its microenvironment are closely related
and constantly interacted. The tumor microenvironment
constitutes to tumor cells within the local environment
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creativecommons.org/publicdomain/zero/1.0/well established that the tumor microenvironment plays
a critical role in the development and metastasis of
cancers. Accumulating studies have evidenced that
tumor-associated mesenchymal stem cells (MSCs) are
involved in the acceleration of cancer progression and
able to promote invasion and migration of cancer cells.
Vice versa, however, cancer cells are also able to ac-
tively modulate nonmalignant stromal cells of tumors,
including mesenchymal cells [1]. The most abundant
stromal cells in the tumor microenvironments are
tumor-associated fibroblasts (TAFs), which are irritatedicle distributed under the terms of the Creative Commons Attribution License
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cancer patients [2]. TAFs display an alternatively activated
phenotype that can directly affect cancer cell growth,
neoangiogenesis and extracellular matrix remodeling [3].
However, whether such a modulating ability of cancer cells
in tumor microenvironments is cancer-type dependent,
and the precise cellular and molecular mechanism of in-
teractions between cancer cells and TAFs undergoing a
malignancy remains unclear.
Mesenchymal stem cells (MSCs) found in many adult
tissues are multipotent progenitor cells that possess a
capacity of self-renewal and multilineage differentiation
[4], and properties of immunomodulation [5]. MSCs have
been proposed as an attractive candidate for the delivery
of anti-tumor agents, owing to their ability to home into
tumor sites and to secrete cytokines [6]. Despite recent
findings suggest that the MSC-secreted soluble factors in
a tumor microenvironment may contribute more signifi-
cantly in tumor progression [7,8], the underlying mecha-
nisms of MSCs in the process of tumor progression are
much less understood, and there are controversial reports
suggest both of tumor-promoting and tumor-inhibiting
roles of MSCs.
Obesity has been associated with numerous negative
health effects including several types of cancer. Fat tissue
is a rich source of both endothelial progenitors and mul-
tipotent MSCs. Adipose MSC (AMSC) phenotypically
resemble bone marrow MSCs (BMSCs) and share their
characteristics of multipotency. There are investigations
show that AMSCs can play a positive role in tumor pro-
liferation and malignancy through multiple signaling
pathways, by which they play a pivotal role in the regula-
tion of cancer growth by modulating Akt activity and
pathways involving in EGFRs, FGFRs, ERbB2 receptor-
mediated pathways [9-11]. In addition, AMSCs are more
likely recruited into tumors, and function to increase
tumor vascularization by endothelial translation, and
elevate proliferation of neighboring malignant cells, as
compared with BMSCs [12]. Zhang et al. shown that a
recruitment of adipose stromal cells by tumors was suffi-
cient to promote tumor growth [13]. Therefore, there is
a necessity to understand the cell-cell communication
between the AMSCs and the cancer cells of tumor,
which may allow us to uncover sequential events that
lead to cancer progression and develop novel agents for
anticancer therapy.
Emerging evidence suggests that multiple cellular ele-
ments in the tumor microenvironment are co-evolved
during the process of carcinogenesis. Bi-directional para-
crine signals coordinately regulate tumorigenic cell pop-
ulations and surrounding cells including MSCs [14,15],
by which tumorigenic cells can produce factors to attract
and regulate a variety of cell types that constitute the
tumor microenvironment. For example, GRP78 secretedby tumor cells can stimulate the differentiation of BMSC
to cancer-associated fibroblasts [16]. Interestingly, many
of the pathways activated during tumor formation re-
semble a cross networks, including cytokine loops and
transcriptional factors [1]. There findings support the
notion of that cancer cells are able to induce AMSCs to
produce paracrine molecules, which in turn promotes
the malignancy of cancer cells.
Stem cell regulatory signaling including the Notch,
Hedgehog, Wnt, PI3K, NF-κB, and Jak/STAT pathways
are frequently dysregulated in tumor cells. These path-
ways are activated in some tumors by mutation of key
regulatory elements. For instance, a dysregulation of
Wnt signaling often occurs in colon cancer, in which the
Wnt signaling is hyperactiviated, since an APC mutation
is always found in this type of cancer [17,18]. Thus, it has
been suggested that the hyperactivated Wnt signaling may
ultimately resulting in an enhanced transcription of spe-
cific genes in the stroma cells of microenvironment of
colon tumor, which in turn promotes the metastasis of
colon cancer [19]. However, the mechanism underpinning
the coordination of cancer cells and AMSCs of tumor
microenvironment in colon cancer metastasis remains
unclear.
In the present study, we sought to identify potential
protein associated with colon cancer malignancy instigated
by prometastatic MSCs using a co-culture cell model. We
found that AMSCs could endow colon cancer cells with en-
hanced tumor-initiating capability and metastatic traits in a
contact dependent manner, when the cancer cells were cul-
tured with AMSCs in comparison with that cultured in
AMSC condition medium alone. The Wnt3a secreted by
colon cancer cells could activate Wnt signaling in AMSCs
and induce AMSCs to trigger the secretion of a select set of
proteins, converge on and increase the expression of the
stemness transcriptional factors and EMT-associated genes.
Materials
Ethics statement
Human adipose tissue was collected with a protocol ap-
proved by the Ethic Committee for the Conduct of Human
Research at Ningxia Medical University. Written consent
was obtained from every individual according to the Ethic
Committee for the Conduct of Human Research protocol.
All participants were provided written informed consent
for the publication of the data. The Human Research Ethic
Committee at Ningxia Medical University approved this
study.
Animals and chemicals
Severe combined immunodeficiency (SCID) mice were
obtained from Vital River Laboratories (VRL). All animal
study was performed with a protocol approved by the
committee of animal care and use at the Ningxia Medical
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products of Sigma-Aldrich (St Louis, MO, USA), unless
otherwise indicated.
Cell cultures
AMSCs were isolated from human adipose tissue of pa-
tient undergone abdominal surgery at the Department
of Surgery in the General Hospital of Ningxia Medical
University. All adipose tissues were resected from tis-
sues >10 cm away from tumor sites. The adipose tissue
was immediately digested with 1 mg/ml collagenase A
(Roche Diagnostic) in Dulbecco’s modified essential
medium F12 (DMEM:F12, 1:1 Gibco) for 60 min at 37°C.
The dissociated tissue was the filtered through a 70 μm
nylon membrane to remove the indigested mass of tissue.
The cell suspension was then centrifuged at 300 g for
10 min, and the cell pellet was resuspened with red blood
lysis buffer (155 mmol/l NH4Cl, 20 mmol/l Tris pH 7.6)
to remove red blood cells. The cells were pelleted by
centrifugation and resuspended in DMEM-F12 (1:1)
medium supplemented with 15% fetal bovine serum
(FBS), 10 ng/ml of bFGF, 1% insulin-transferrin-selenium
(ITS) (Gibco), 1% pen-strep (Gibco). The collected cells
were the fraction of stroma cells of the adipose tissue. The
isolated stroma cells were then seeded in plastic plates at
the initial density of 3.2 × 104 cells/cm2 non-adherent cells
were removed by changing the culture medium. The cells
were refreshed twice a week. Colon cancer cell lines,
HCT116 cells (ATCC # CCL-247), LoVo cells (ATCC #
CCL-229), SW480 (ATCC # CCL-228), LS174T (ATCC #
CL-188), CCD-18Co (ATCC # CRL-1459) were grown in
Dulbecco’s modified essential medium with 10% FBS.
Co-culture system
In order to investigate functions of AMSCs in the progres-
sion of colon cancer, colon cancer HCT116 cells were ei-
ther cultured in a cell co-culturing model, in which
HCT116 cells were cultured on transwell of 0.4 μm pore
size membrane (up chamber) and AMSCs were cultured
on the bottom chamber of the culturing well, or cultured
with conditional medium of human AMSCs (AMSC-CM).
To prepare AMSC-CM, a confluent AMSC culture was
refreshed with serum-free basic medium and cultured for
additional for 24 h, the supernatant of culture was then
collected as basic conditioned medium for preparation of
AMSC-CM.
Flow cytometry assay
The Flow cytometry assay was conduced by using
AMSCs cultured at passage three (P3). Following the
culturing, the cells were harvested and extensively
washed prior to be labeled with fluorescent-conjugated
(PE or FITC) antibodies to CD105, CD90, CD73, CD45,CD116 and CD34. The flow cytometry analysis was per-
formed on BD FACSCalibur™ platform.
ELISA assay
AMSCs were seeded alone or separated from transwell
apparatus that co-cultured with HCT116 and refreshed
with regular culture medium for additional 24 h. The
culture media were then collected and used for accessing
the secretion of paracrine factors (FGF10, VEGFC, TNFα
and IL10) by ELISA using commercial available kits
(eBiosciences, CA). The number of AMSCs was also
counted for the subsequent assessment.
Immunohistochemistry and immunofluorescence staining
The cells were fixed in 4% paraformaldehyde (PFA) at
room temperature (RT) for 30 min, and permeabilized
with 0.1% Triton X-100 in PBS for 10 min. The slides
were then blocked with 3% BSA (Sigma) in PBS at RT for
1 h, followed by incubating with the primary antibody to
vimentin (1:100, SantaCruz, USA) or E-cadherin (1:100,
SantaCruz, USA) at 4° overnight. Cy3-labelled anti-rabbit-
IgG secondary antibody was used for visualization of spe-
cific signal under a fluorescent microscope. The nuclei of
cells were count stained with DAPI-Fluoromount-G.
MTT assay
An MTT (methyl thiazoly tetrazolium) assay was
employed to ascertain the cell viability. HCT116 cells
were seeded at densities 2000 cells per well in 96-well
plate. The proliferation of cells was measured by an
MTT assay daily from day 2 to day 7 of culturing. Briefly,
20 μL of 5 mg/mL MTT (Sigma) solution was added to
each well and incubated at 37°C for 4 h, after which the
medium was replaced by 100 μL of DMSO (Sigma) and
incubated for additional 10 min. The capacity of cell pro-
liferation was then determined by Microplate spectropho-
tometer at 560 nm (Bio-Rad Laboratories Inc., Hercules,
USA). Data represent the mean of six wells for each point.
Colony formation assay
HCT116 cells were seeded at a density of 1 × 105/well
into 60 mm culture dishes, and cultured with DMEM
containing 0.5% of FBS at 37°C for two weeks. The cul-
tures were washed twice with PBS prior to be stained
with 0.1% crystal violet solution. The number of colonies
containing >50cells was counted under a microscope.
The experiments were performed in triplicate.
Transwell invasion assay
The apical surface of Transwell membrane (8 μm pore
size, BD Bioscience) was coated with Matrigel (BD
Bioscience). 40 μl of Metrigel (1:5 matrigel: DMEM)
was applied onto each of the upper chamber of 12 mm
Transwell insert. The insert was then incubated at 37°C
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different groups were suspended in 200 μl of 0.5% serum
medium and seeded on the top of gel, and 500 μl of
medium supplemented with 10% FBS were added to the
lower compartment of culture chamber. After 24 h of in-
cubation, the cultures were fixed with 4% paraformalde-
hyde, and stained with 0.1% crystal violet for determining
cells migrated to the basolateral surface of the membrane
under a light microscope. All experiments were performed
in triplicate.
Quantitative real-time polymerase chain reaction (qRT-PCR)
Total RNA was extracted using miRNeasy kit (QIAGEN)
and was processed for reverse transcription (RT) with a
RT kit (Thermo) per manufacturers’ instructions. The
quantitative PCR was carried out on an IQ5 thermal cy-
cler (BIO-RAD, USA) and Maxima® SYBR Green/ROX
qPCR Master Mix (Thermo) using gene specific primers
(Table 1).
Western blot analysis
Cells were lysed with RIPA buffer (Thermo Scientific,
USA) included DTT, PMSF, protease inhibitor cocktail
and phosphatase inhibitor cocktail (Active Motif, USA)
and the protein concentration was determined using
Pierce BCA protein Assay kit per the manufacturer’s in-
struction (Thermo Scientific, USA). 20 μg of protein was
resolved using a 10% SDS-PAGE Gel prior to be trans-
ferred on PVDF membrane (Life Technologies, USA).
The membranes were blocked with 5% BSA for 1 h and
probed with respective primary antibodies overnight
such as Anti-phospho-β Catenin (Ser37) (Millipore, Cat.
No. NG1664798), GSK-3β (Transduction Laboratories
Cat. No. G22320), anti-phos-GSK3β (Millipore, Cat. No.
05–413), and Anti-Active-β-Catenin (Anti-ABC) Anti-
body (Millipore, Cat. No. 05–665), followed by incubat-
ing with appropriate secondary antibody conjugated
with HRP (Santa Cruz Biotechnology, USA) at RT for
1 h. The interest proteins were detected by ECL kit
(Santa Cruz Biotechnology, USA). Blot images were cap-
tured using ChemiDoc MP (BIO-RAD, USA). Densitomet-
ric analysis was performed using ImageJ software and
values were normalized with loading control (GAPDH).
In vivo analysis of tumorigenetic capacity
The tumorigenic capacity of HCT116 co-cultured with
AMSCs was evaluated in 6–8 week-old of female SCID
mice. The mice were subcutaneously inoculated (s.c.)
with 200 μL Matrigel (BD Bioscience) containing 5 × 106
of cancer cells. The animals were euthanized and the tissues
of injection sites were collected for analysis of tumorigen-
icity eight weeks after the injection. The harvested tissues
were then used for histological and proliferation analysis by
HE (hematoxylin and eosin) histochemistry staining andimmunohistochemistry (IHC) staining using anti-Vementin
and E-cadherin antibodies (Santa Cruz biotect, Santa cruz,
CA, USA), respectively. 9 SCID mice were analyzed for
each group.Statistical analysis
All statistical analyses were performed using SPSS statis-
tical analysis software (SPSS Inc., Chicago, IL, USA).
The results were presented as the mean ± standard devi-
ation (SD) for comparison of individual conditions, and
differences between the groups were tested by one-way
ANOVA with a post-hocleast square difference (LSD)
test. A p < 0.05 was defined as a statistical significance.Results
AMSCs enhance colon cancer stem cell-like property
In order to seek whether AMSCs have an impact on colon
cancer cells, colon cancer HCT116 cells were primed with
human AMSCs using either an in vitro co-culture model
(co-cul) or AMSC-CM (cm-cul), and the alteration of ex-
pression of stem cell markers and EMT markers was eval-
uated by a qRT-PCR assay. Results revealed that the
expression of EMT-associated genes ZEB1, ZEB2, Slug,
Snail and Twist (Figure 1A), and “stemness” genes Oct4,
Sox2, Nanog, Bmi1 (Figure 1B) was markedly up-regulated
in both conditions of co-cul and cm-cul, as compared with
the untreated control HCT116 cells. Of note, the EMT-
related gene, E-cadherin was significantly down-regulated
(Figure 1A). More importantly, more robust expression of
these genes was observed in HCT116 cultured in the co-
culture model relative to the cells cultured using AMSC-
CM. The proliferating ability of colon cancer cells was also
enhanced in a co-culture condition as determined by an
MTTassay (Figure 1C). Equally noteworthy, the malignant
potential of HCT116 cells cultured in the co-culture
model or with AMSC-CM was dramatically enhanced as
compared to the controls (Figure 1D-F). Morphologically,
HCT116 cells were altered from a rounded shape to an
elongated one, morphology of cell with capacity of EMT,
at day 7 following the co-culture, albert the expression of
E-cadherin and vimentin proteins was detected in
HCT116 cells (Figure 1D). Such an AMSC-enhanced
migratory capacity of HCT116 cells was further supported
by the results of transwell invasion assay (Figure 1E) and
colony formation assay (Figure 1F), in which HCT116
cells co-cultured with AMSCs or cultured with AMSC-
CM showed an enhanced ability of invasion (Figure 1E)
and colony formation (Figure 1F), as compared with
cells cultured in regular medium. These observations
suggested that AMSCs could enhance the malignant
capacity of HCT116 cells, implying that AMSCs may
play a role in promoting tumor-associated phenotypes
of colon cancer cells.
Table 1 Primers and probes used for qPCR assays
Gene Sequence 5′→ 3′ Gene Sequence 5′→ 3′
ZEB1 F: TTGGTTTGGTGTCTCCCATAAGT IL-10 F: GAGAACCAAGACCCAGACATCAAG
R: ACATTACCATCTACCGCCACTTTA R: GGCATTCTTCACCTGCTCCAC
Snail F: GACCCCAATCGGAAGCCTAA LIF F: CAGTGCCAATGCCCTCTTTATT
R: TGGTCGTAGGGCTGCTGGA R: GGAGGTGCCAAGGTACACGACT
Slug F: GAAGAGGAAAGACTACAGTCCAAGC INFγ F: TCAGATGTAGCGGATAATGGAACT
R: CCAGGCTCACATATTCCTTGTCA R: CATTCATGTCTTCCTTGATGGTCT
Twist1 F: GCAAGAAGTCTGCGGGCTG IL1β F: TTATTACAGTGGCAATGAGGATGAC
R: AACGCCTCGTTCAGCGACT R: TGCTGTAGTGGTGGTCGGAGA
E-cadherin F: AAGGCAAGGTTTTCTACAGCATC TNFα F: GAGTGACAAGCCTGTAGCCCAT
R: CCATTGGATCCTCAACTGCATT R: CCTTGAAGAGGACCTGGGAGT
Oct-4 F: CTTGCTGCAGAAGTGGGTGGAGGAA TGFβ F: TGCCCCGAGTGCTACTTTGA
R: CTGCAGTGTGGGTTTCGGGCA R: GCAACTGACGCAGCAGAAATG
Nanog F: CAGAAGGCCTCAGCACCTAC MMP1 F: TGAAGAATGATGGGAGGCAAGTT
R: ATTGTTCCAGGTCTGGTTGC R: AGGGTTTCAGCATCTGGTTTCC
Sox2 F: AGCTACAGCATGATGCAGGA MMP2 F: GACAGTGGATGATGCCTTTGCT
R: GGTCATGGAGTTGTACTGCA R: GGAGTCCGTCCTTACCGTCAA
Bmi1 F: CCTCATCCACAGTTTCCTCACAT MMP9 F: TCCACCCTTGTGCTCTTCCCT
R: TATTGGCAAAAGAAGATTGGTGG R: CTGCCACCCGAGTGTAACCAT
C-MYC F: ATACATCCTGTCCGTCCAAGCA MMP11 F: AGTGCCCGCAACCGACAG
R: ACAAGAGTTCCGTAGCTGTTCAAG R: GGCGTCACATCGCTCCATAC
VEGFA F: TGTGAATGCAGACCAAAGAAAGA ICAM1 F: GTGCTATTCAAACTGCCCTGATG
R: CAGGGAACGCTCCAGGACTTAT R: CTGGCAGCGTAGGGTAAGGTTC
VEGFC F: TCTGGAGGAGCAGTTACGGTCT COL1A1 F: CAAGACGAAGACATCCCACCAAT
R: GTTATGTTGCCAGCCTCCTTTC R: ACAGATCACGTCATCGCACAAC
VEGFD F: ATCGGTCCACTAGGTTTGCG COL6A1 F: GAGACGATAACAACGACATTGCA
R: AACAGCCACCACATCGGAAC R: GATGATGTCCAAAATCTCGCATT
FGF2 F: TACCTGGCTATGAAGGAAGATGG β-catenin F: GTGGTATAGAGGCTCTTGTGCG
R: AGTTCGTTTCAGTGCCACATACC R: TCCAACAGTAGCCTTTATCAGAGG
FGF10 F: TAACTGGCAGCATAATGGGAGG Wnt3a F: CGGTGACTTCCTCAAGGACAAG
R: CCATTGGAAGAAAGTGAGCAGAG R: AGGAGCCCGTCTCAGGGTT
HGF F: ATTGCCCTATTTCTCGTTGTG CD44 F: ATCACCGACAGCACAGACAGAATC
R: GCATTTCTCATCTCCTCTTCC R: GAAACAACCATGAAAACCAATCCC
IGF F: CGCTGTGCCTGCTCACCTTC CyclinD1 F: TGTCGCTGGAGCCCGTG
R: GCCATACCCTGTGGGCTTGT R: GGATGGAGTTGTCGGTGTAGATG
IL6 F: AATGAGGAGACTTGCCTGGTGA ZEB2 F: TCCCTTCTGCGACATAAATACG
R: GGTTGGGTCAGGGGTGGTTAT R: CATGTGCTGCGAGTACGAGC
IL8 F: CTCTTGGCAGCCTTCCTGATTT GAPDH F: GTGGACCTGACCTGCCGTCT
R: GGTGGAAAGGTTTGGAGTATGTCTT R: GGAGGAGTGGGTGTCGCTGT
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We next sought to whether colon cancer cells were
able to alter the property of AMSCs. The cell surface
phenotype and multipotent differentiation potential of
AMSCs after co-culturing with colon cancer cells were
first explored. To evaluate the differentiation potentialof AMSCs after co-culture with HCT116 cells, the
AMSCs were cultured with induction medium for adi-
pogenesis or osteogenesis. As shown in Figure 2A, oil
red O staining showed accumulated triacylglycerol
staining of adipogenesis, and Alizarin red S staining
showed mineral depositions of osteogenesis in the cell
Figure 1 AMSCs enhance malignancy of colon cancer cells in a transwell co-culture model. Colon cancer cells were co-cultured with AMSCs
using a transwell model. The malignancy of HCT116 cells was ascertained by examining the expression of EMT- and stemness-related genes, and
capacities of proliferation, invasion and colony formation. (A) The transcripts of EMT-associated genes in HCT116 treated with indicated conditions
were determined by a qRT-PCR assay. (B) The transcripts of stemness-related genes in HCT116 treated with indicated conditions were determined
by a qRT-PCR assay. (C) The proliferation of HCT116 cells cultured in the indicated conditions was analyzed by an MTT assay. (D) Immunofluorescent
analysis of E-cadherin and vimentin proteins in HCT116 cells cultured in regular medium or in the co-culture system as described in (A). The scale bar
represents 20 μm. (E) The capacity of invasion of HCT116 cells in the indicated conditions was detected by a transwell invasive assay. Left
panel: representative images of indicated condition; right panel: numbers of invaded cells in indicated conditions. (F) The capacity of colony
formation of HCT116 cells in the indicated conditions was detected by a sphere formation assay. Left panel: representative images of indicated condition;
right panel: numbers of sphered cells in indicated conditions. Data represented as mean ± SD from three independent triplicated experiments (N = 9).
Compared to the control, *p < 0.05; **p < 0.01; ***p < 0.001.
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AMSCs demonstrated that over 90% of AMSCs remained
their ability to express MSC surface immunophenotypic
markers, such as CD105, CD73 and CD90, but lack expres-
sion of hematopoietic markers CD34 and CD45 (Figure 2B).These data indicated that the characters of AMSCs
were unaltered after they were co-cultured with HCT116
cancer cells, as compared with the original P3 AMSCs
(Figure 2A, B). Intriguingly, in the culture of AMSCs con-
tacted with HCT116 cells showed an elevated abundance
Figure 2 HCT116 cells alter the expression of paracrine factors in AMSCs of co-culture model. P3 AMSCs were co-cultured with HCT116 cells in a
transwell model. The characteristics and differentiate properties, and abilities of the expression of paracrine factors and cytokines in the co-cultured P3
AMSCs were examined. (A) The morphology and differentiation of original P3 AMSCs and AMSCs in the co-cultured model. AMSCs showed a
normal MSC morphology and potency of osteogenic and adipogenic differentiation. The scale bar represents 20 μm. (B) Flow cytometry
analysis for MSC-specific phenotype of AMSCs in the co-culture model. The HCT116 co-cultured P3 AMSCs retained a normal AMSC
immunophenotype. (C-E) The alteration of expressions of indicated paracrine factors (C), cytokines (D) and EMT-associated genes in
AMSCs was determined by a qRT-PCR assay. (F) Concentration of indicated paracrine factors and cytokines of the culture medium was
ascertained by an ELISA. Data represented as mean ± SD from three independent triplicated experiments (N = 9). Compared to the control,
*p < 0.05; **p < 0.01; ***p < 0.001.
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(Figure 2C), cytokines of TNFα, IL10 and INFγ (Figure 2D),
and extracellular matrix MMP1, MMP2, and MMP11
(Figure 2E). In addition, the increased expression of several
above genes was further validated at protein level by ELISA,
by which more abundant proteins of VEGFC, FGF10,
TNFα and IL10 were detected in AMSCs co-cultured
with HCT116 cells (Figure 2F). These results suggest
that colon cancer cells may enhance paracrine signaling
of AMSCs within a cancer microenvironment.Colon cancer cells activate Wnt signaling in AMSCs
In order to explore which developmental signaling pathway(s)
of colon cancer cells are involved in the up-regulation of
metastasis-related genes in AMSCs, the role of canonical
Wnt signaling in the regulation of paracrine activity of
colon cancer cells was interrogated. The baseline activities
of canonical Wnt signaling in colon cancer cell lines
and colorectal carcinoma (CRC) tissues were examined
by accessing the expression of Wnt3a and β-catenin.
More abundant β-catenin and/or Wnt3a transcripts
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HCT116 cells and CRC tissues, but not LoVo cells as
compared with the normal colonic epithelial cell line
CCD-18Co (Figure 3A). However, in comparison withFigure 3 The activated canonical Wnt signaling of colon cancer cells induc
Wnt signaling molecules and its target genes in HCT116 and AMSCs of co-
cells. (A, B) The alteration of transcripts of Wnt3a and beta-catenin as well
(Ser37) β-Catenin and phosphorylated (Tyr279/Tyr216) GSK3β (A), and indic
models (B) was determined by a qRT-PCR assay. (C) Representative images
Wnt3a and beta-catenin of AMSCs cells cultured in indicated conditions. Th
Wnt signaling and its target genes in cells cultured in an indicated conditions. G
nuclear proteins, respectively. Top panel: immunoblots of indicated proteins; bo
densitometry analysis. Compared to the control, *p < 0.05; **p < 0.01; ***p < 0.00normal epithelial CCD-18Co cells, all colon cancer cells
and CRC tumor tissues exhibited less phosphorylated
β-catenin proteins and more phosphorylated GSK3β pro-
teins, indicative of activated Wnt/β-catenin signaling. Ines TAM phenotypes of AMSCs in co-culture model. The expression of
culture model was detected for examining Wnt activation in these
as protein expressions of actived actived β-catenin, phosphorylated
ated Wnt target genes of different colon cancer cells or in co-culture
of confocal fluorescent microscopy of immunofluorescent staining for
e scale bar represents 20 μm. (D) Immunoblotting assay for indicated
APDH and Histone H3 in A severed as loading controls for cytosolic and
ttom panel: fold changes of interest proteins in top panel quantified by a
1.
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creased expression of active β-catenin protein and a less
abundant phosphorylated (Ser37) β-Catenin by inhibition
of GSK3β (Figure 3A) relative to other tested cancer cell
lines. In contrast, LoVo cells displayed the least abundant
β-catenin transcripts and β-catenin activity among the
tested colon cancer cell lines (Figure 3A). HCT116 and
LoVo cells were thus used in further studies in co-culture
model. AMSCs co-cultured with HCT116 cells or LoVo
cells exhibited marked increases of the expression of Wnt
target genes, including CD44, c-MYC, CyclinD1, and
CTNNB1 as determined by a qRT-PCR assay (Figure 3B).
Immunofluorescent staining further revealed that Wnt3a
and beta-catenin proteins were elevated in AMSCs when
they were co-cultured with HCT116 cells (Figure 3C), in-
dicative of an activation of canonical Wnt pathway. Fur-
thermore, immunoblotting assay revealed that the nuclear
beta-catenin protein was significantly increased in AMSCs
co-cultured with HCT116 cells, despite AMSCs co-
cultured with LoVo cells only showed a decent increase of
nuclear beta-catenin expression, in comparison with the
control AMSCs (Figure 3D). Together, these observations
suggest that Wnt signaling pathway may play a unique
role in activation of both VEGFC and FGF10 signaling,
highlighting that an activation of Wnt signaling may be a
potential common effect for AMSCs in response to Wnt-
activated cancer cells in multiple settings.
The effect of AMSCs-induced EMT on stem cell-like
behavior through canonical Wnt signaling pathway
Since Wnt-excretive cancer cells activate AMSCs that
can in turn induce CSC-traits of cancer cells, we investi-
gated the impact of Wnt signaling of cancer cells on
AMSCs. Wnt signaling inhibitor IWP-2 was employed
to as an antagonist of the Wnt/β-catenin pathway by
blocking Wnt secretion and activity. Western blotting
assay showed that an addition of IWP2 led a decreased
accumulation of nuclear β-catenin in HCT116 co-
culture with and without AMSCs (Figure 4A), expres-
sion of stemness genes (Slug, Snail, Twist, Oct4, Sox2,
Nanog, Bmi1) (Figure 4B) and the EMT related genes
(ZEB1, ZEB2, FGF10, VEGFC, TNFα, IL10 and MMPs)
(Figure 4C) in AMSCs co-cultured with HCT116 cells.
In addition, the presence of IWP-2 could dramatically
inhibit the secretion of FGF10 and VEGFC protein in the
AMSC culturing medium (Figure 4D). The capacities of
invasion (Figure 4E) and colony formation (Figure 4F) of
cancer cells were also reduced when the IWP2 was added
in the co-culture system, while an addition of IWP2 re-
sulted in a significant decrease of mammosphere colony
formation in suspension by 3-fold (Figure 4F). Import-
antly, in vivo tumorigenic analysis demonstrated that
IWP2 was able to inhibit the tumorigenicity of HCT116
cells cultured with AMSCs. SCID mice subcutaneouslyinjected with the IWP2 treated and AMSCs co-cultured
HCT116 cells were found to develop smaller tumors
in comparison with the untreated co-cultured cells
(Figure 4G). Results from IHC staining further revealed
that tumor samples generated with IWP2-treated AMSCs-
co-cultured HCT116 cells expressed more abundant E-
cadherin and less vimentin proteins, as compared with the
untreated AMSCs-co-cultured HCT116 cells (Figure 4H).
This result suggested a reduced malignancy of HCT116
when the Wnt signaling in co-cultured system was inhib-
ited. Together, these results indicate that FGF10 and
VEGFC may be candidate paracrine factors responsible for
the malignancy of cancer cells induced by Wnt-activated
AMSCs. Of note, a robust induction of FGF10 and VEGFC
by AMSCs may require cancer cells with abundant activa-
tion of canonical Wnt signaling.
Discussion
Interactions between MSCs and tumor cells involves a
number of MSC secreted signaling molecules that may
stimulate various signaling pathways, in particular re-
lated to cell growth and apoptosis regulation in the
tumor cells. However, the crosstalk of tumor–MSC cells
is complex, which involves in signaling from both of
tumor cells and surrounding MSCs to control the tumor
progression [20]. In this study, we show that cancer cells
can secrete canonical Wnt signaling ligands (Wnt3a) to ac-
tivate AMSCs to a TAF-like phenotype. As a consequence,
the activated AMSCs can in turn produce FGF10 to induce
CSC-traits of cancer cells. A crosstalk between the cancer
cells and AMSCs thus may be essential to promote the
tumor initiating of colon cancer cells and is associated with
poor prognosis in colon cancer patients. In the primary
tumor, cancer stem cell may arise from the transformation
of resident stem cells or from dedifferentiation of differenti-
ated tumor cells in response to specific microenvironmental
signals [21]. It is therefore clear that the crosstalk between
tumor cells and their surrounding microenvironment is
required for CRC development. The delineation of key
molecular pathways has enhanced our knowledge of the
biology of tumor microenvironment, tumor dissemination,
and carcinogenesis. The complexities of cell-cell communi-
cation and the possibilities for modulation provide new
avenue for cancer treatments. However, the understanding
of the dynamic regulation of relationships between cells in
the tumor microenvironment was still indistinct.
During a progression of cancer development, cancer
cells and the surrounding microenvironment constantly
communicate each other through a biochemical and/or
a biophysical cues. In this regard, signaling molecules in
the microenvironment play an indispensible role in con-
trolling cancer cells to undergo an EMT and promote
the invasion and metastatic dissemination of cancers. In
general, signaling molecules are not independent from
Figure 4 (See legend on next page.)
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Figure 4 The Wnt signaling plays a key role in the production of paracrine factors of AMSCs malignancy of colon cancer cells in co-culture
model. HCT116 cells were co-cultured with AMSCs in the presence of Wnt signaling inhibitor IWP2, and the production of paracrine factors of
AMSCs and the malignancy of HCT116 cells were investigated in vitro and/or in vivo assays. (A) Representative immunoblots of nuclear beta-catenin from
HCT116 cells cultured in indicated conditions (top panel) and their fold changes quantified by a densitometry analysis (bottom panel). (B-C) The alterations
of transcripts of indicated EMT- and stemness-related genes of HCT116 cells (B), and indicated cytokines and MMPs genes of AMSCs in different conditions
(C). (D) The concentration of indicated paracrine factors in the culture medium. (E) The capacity of invasion of HCT116 cells in the indicated conditions. Left
panel: representative images of indicated condition; right panel: numbers of invaded cells in indicated conditions. (F) The capacity of colony formation of
HCT116 cells in the indicated. Left panel: representative images of indicated condition; right panel: numbers of sphered cells in indicated conditions. (G)
The in vivo tumorigenitic assay showed a repression of tumorigenicity of HCT116 cells in co-culture model with IWP2 as ascertained by the size (left panel)
and weight (right panel) of subcutaneous primary tumors derived from SCID mice at 8 weeks after the injection of HCT116 cells. (H) Representative H&E
and IHC staining of E-cadherin and vimentin in the primary tumors derived from SCID mice in (G). Scale bars represent 20 μm. GAPDH was
used as an endogenous control for normalization. Data represented as mean ± SD from three independent triplicated experiments (N = 9).
Compared to the control, *p < 0.05; **p < 0.01; ***p < 0.001.
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naling network. In the present work, we found that
AMSCs could induce EMT and enhance the invasive
capability in colon cancer HCT116 cells. Epithelial colon
cancer cells undergoing an EMT show mesenchymal fea-
tures with loss of polarity and stem like spindle shape,
which is closely associated with motility, metastasis and
invasiveness. The EMT has also been connected to in-
duction of cancer stem cells [22], drug resistance [23],
and immune suppression. In this regards, many similar
findings were also reported in varying models. Interest-
ingly, we found that cell communication by a direct or
an indirect manner resulted in distinct consequences, a
direct co-culture of cancer cells with AMSCs showed a
significantly enhanced potential malignancy of cancer
cells, in comparison with the cancer cells cultured in the
AMSCs conditional medium, as determined by the ex-
pression of stemness genes Oct4, Nanog, Bmi1 and Sox2.
The role of Bmi1 and Nanog in regulating stemness and
drug resistance of breast cancer cells has been verified
[24]. Thereby, we hypothesized that cancer cells might
play a role in activating tumor-associated phenotypes of
AMSCc, and in turn, the activated AMSCs could affect
the ability of cancer cells through the paracrine signaling
pathways. Indeed, extracellular signaling of FGF10,
VEGFC, IL10 and TNFα of AMSCs was dramatically in-
duced when they were co-cultured with cancer cells, and
these molecules are suggested to have a direct or indir-
ect impact on Wnt signaling pathway. This notion is
supported by studies from others. For instance, Cohen
et al. reported that Wnt3a could significantly increase
the expression of FGF10 and a novel Wnt-FGF signaling
axis was required for expansion of Isl-1–positive anterior
heart field progenitors [25]. The finding of that Wnt-
induced FGF-10 secreted by parabronchial SMC is essen-
tial for epithelial repair after naphthalene injury is another
example [26].
Noteworthy, an increased expression of FGF-10, VEGFC,
IL-10 and TNFα of AMSCs was found to be along with an
elevated EMT gene expression of colon cancer cells in theco-culture model in this study. The important role of FGF-
10 in type III EMT of cancer cells and the initiation of me-
tastasis through various signaling pathways has also been
suggested [27]. In the present study, we found that FGF10
was mainly responsible for the activation of AMSCs, which
may in turn promotes the EMT of cancer cells to form the
self-reinforcing loop. Accumulating studies suggest that
ASCs like MSCs are capable of promoting angiogenesis
through the secretion of growth factors, in particular
VEGFC [28], since angiogenesis is a well-known crucial
event for cancer growth, and VEGF secretion plays a
pivotal role in this process. In addition, a novel Rspo1-
Wnt-Vegfc-Vegfr3 signaling pathway has been defined
to play an essential role in developmental angiogenesis
[29], and an aberrant expression of VEGFC was re-
cently found to be associated with lymph node metasta-
sis in intrahepatic cholangiocarcinoma (IHCC) [30].
Here, we also found a decent increase of VEGFC in
AMSCs, suggesting that VEGFC secreted by AMSCs
may be in part attributed the increased expression of
EMT gene in colon cancer cells.
In addition to the FGF10 and VEGFC, the expression
of inflammatory factors IL-10, INFγ and TNFα was also
increased in co-cultured AMSCs. Inflammations have
long been recognized to be associated with cancer devel-
opment, in which cancer cells can recruit activated fi-
broblasts and immune cells that in turn secrete varied
cytokines to induce cancer development and metastasis
in part by directly regulating the EMT program [31,32].
In this context, several recent clinical studies showed
that IL-10 was an immune suppressor of different can-
cers that able to lead an adverse outcome in terms of
immune tolerance [33,34]. In addition, an activation of
beta-catenin signaling can program dendritic cells to a
tolerogenic state, and limits the inflammatory response
by IL-10 [35]. Moreover, Razmkhah et al. recently found
that resident adipose stem cells (ASCs) in breast cancer
tissue might play crucial roles in breast tumor growth
and progression by inducing regulatory molecules and
promoting anti-inflammatory reaction within the tumor
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An up-regulated IL-10 was also found in AMSCs co-
cultured with colon cancer cells in this study. Apart
from inflammatory cytokines, MMPs in the tumor
stroma are also important elements that play key roles
in the matrix remodeling, inflammation, angiogenesis,
cell growth and migration of cancers, in either a proteo-
lytic or a nonproteolytic manner [37]. Indeed, a previous
study using a co-culture model of breast cancer cells
and bone marrow MSCs showed that cancer cells could
induce a up-regulated expression of MMPs in MSCs,
along with elevated expression of EMT related genes in
cancer cells [38].
The role of MSC signaling through Wnt in cancer pro-
gression has been reported in previous publications, des-
pite an inhibitory effect on tumor growth was reported
in a study using Z3-MSCs, a cell line producing Dkk-1,
an inhibitor of Wnt/β-catenin signaling [20,39]. In this
study, we assume that an activation of Wnt signaling is
an effect of AMSCs response to Wnt signaling hyperac-
tivated cancer cell lines that aberrantly expressing Wnt
ligands, such as the Wnt3a, an essential component in
the Wnt signaling pathway. Indeed, the Wnt signaling of
AMSCs was activated when they were co-cultured with
cancer cells; sequentially the Wnt-activated AMSCs in-
creased their expressions of EMT genes, including
FGF10, VEGFC, MMPs, and cytokines. These signaling
molecules in turn positively activate Wnt signaling of
cancer cells to form a positive paracrine factor feedback
loop, which leads to an uncontrolled cell growth, prolif-
eration and invasion of cancer cells.Conclusions
In summary, this study demonstrates an important role of
the crosstalk between colon cancer cells and AMSCs in in
the metastatic potential of colon cancer cells. The paracrine
factors of stroma cells in cancer microenvironment are es-
sential for cancer cells to maintain or promote their cap-
acity of invasion and migration, which could be a potential
therapeutic target for colon cancer metastasis. In this con-
text, the CSCs are regulated by complex interactions with
the components of the tumor microenvironment including
mesenchymal stem cells, through microenvironmental net-
works of cytokines and growth factors. Since these compo-
nents have a direct effect on metastatic properties of cancer
cells, they represent attractive therapeutic targets for colon
cancer treatment.Abbreviations
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